Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma.
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Abstract Background Males < 40 years old are more likely to be diagnosed with and die from osteosarcoma (OS). The underlying mechanisms may depend on sex differences in immune response. Methods We used SEER data to estimate survival differences between males and females aged < 40 years at OS diagnosis. In NCI TARGET-OS cases, we determined sex differences in gene expression, conducted Gene Set Enrichment Analysis (GSEA), and applied the LM22 signature to identify biologic sex differences. We compared sex differences in gene expression profiles in TARGET-OS to those observed inSleeping Beauty(SB) transposon mutagenesis acceleratedTrp53R270H-mutant mouse-OS and healthy adult osteoblasts. Results Males had worse 17-year overall survival than females (SEERp< 0.0001). From 87 TARGET-OS cases, we observed 1018 genes and 69 pathways that differed significantly by sex (adjustedp< 0.05). Pathway and gene lists overlapped with those from mice (p= 0.03) and healthy osteoblasts (p= 0.017), respectively. Pathways that differed significantly by sex were largely immune-based and included the PD-1/PD-L1 immunotherapy pathway. We observed sex differences in M2 macrophages (LM22;p= 0.056) and M1-M2 macrophage transition (GSEA;p= 0.037) in TARGET-OS. LM22 trends were similar in mice. Twenty-four genes differentially expressed by sex in TARGET-OS had existing cancer therapies. Conclusions Sex differences in OS gene expression were similar across species and centered on immune pathways. Identified sex-specific therapeutic targets may improve outcomes in young individuals with OS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the greater proportion of males in the LEN-IE vs IE arm (25 patients [62.5%] vs 21 patients [51.2%]) may have influenced the efficacy outcomes in OLIE, as previous research has suggested that males with osteosarcoma have worse outcomes than females.”
From Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma (2024) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“previous research has suggested that males with osteosarcoma have worse outcomes than females.”
From Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma (2024) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
Visualizing and interpreting cancer genomics data via the Xena platform
Goldman, M. J., Craft, B., Hastie, M., Repečka, K., McDade, F., Kamath, A., Banerjee, A., Luo, Y., Rogers, D., Brooks, A. N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0546-8 · Cited by 4,481 · cited 1×
“87 of the 285 TARGET cases to determine sex differences in gene expression [21].”
BackgroundMassive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · cited 1×
“Investigations into the somatic landscape of pediatric OS have reported much lower mutation frequencies than adult tumors [8], shown complex karyotypes characterized by chromosome arms losses/gains [9], and found frequent chromothripsis [10].”
BackgroundMirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
The reactome pathway knowledgebase
Jassal, B., Matthews, L., Viteri, G., Gong, C., Lorente, P., Fabregat, A., Sidiropoulos, K., Cook, J., Gillespie, M., Haw, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1031 · Cited by 2,159
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572 · cited 1×
“Investigations into the somatic landscape of pediatric OS have reported much lower mutation frequencies than adult tumors [8], shown complex karyotypes characterized by chromosome arms losses/gains [9], and found frequent chromothripsis [10].”
BackgroundOsteosarcoma: Current Treatment and a Collaborative Pathway to Success
Isakoff, M. S., Bielack, S. S., Meltzer, P., & Gorlick, R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,567
Research works printed but not linked: 1
- Mirabello L Troisi RJ Savage SA Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program Cancer. 2009 115 7 1531 1543 19197972 PMC2813207 · DOI · Paper page
Cited by
Biz, C., Khamisy‐Farah, R., Puce, L., Szarpak, Ł., Converti, M., Ceylan, H. İ., Crimì, A., Bragazzi, N. L., & Ruggieri, P. (2024) · Biomedicines · doi:10.3390/biomedicines12050974 · Cited by 40
Zhao, Y., Chen, D., Yin, J., Xie, J., Sun, C., & Lu, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.788580 · Cited by 40
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma
Gaspar, N., Hung, G.-Y., Strauss, S. J., Campbell-Hewson, Q., Dela Cruz, F. S., Glade Bender, J. L., Koh, K.-N., Whittle, S. B., Chan, G. C.-F., Gerber, N. U., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.4381 · Cited by 28
Williams, L. A., Barragan, S., Lu, Z., Weigel, B. J., & Spector, L. G. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102565 · Cited by 18
Self-citationZhang, L., Jiang, H., & Ma, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548527 · Cited by 16
Metadata
- Authors
- Mills, L. J., Spector, L. G., Largaespada, D. A., & Williams, L. A.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Williams, Lindsay A.
- Venue
- Biology of Sex Differences
- Published
- 2021-01-06
- Volume
- 12
- Issue
- 1
- Pages
- 5-5
- ISSN
- 2042-6410 (ISSN-L)
- PMC
- PMC7789366
- OpenAlex
- W3120547481
- Cited by
- 17
- References
- 49
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Biology of Sex Differences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Children's Cancer Research Fund
- American Cancer Society
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- osteosarcoma, sex differences, sex differences in gene expression, immune response, M2 macrophages, PD-1/PD-L1 pathway, immunotherapy, overall survival, osteoblasts
- MeSH terms
- Animals, Bone Neoplasms, Female, Male, Osteoblasts, Osteosarcoma, Sex Characteristics, Mice, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma. https://app.cochat.ai/papers/10.1186/s13293-020-00347-y
- The paper
- Mills, L. J., Spector, L. G., Largaespada, D. A., & Williams, L. A. (2021). Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma. Biology of Sex Differences. https://doi.org/10.1186/s13293-020-00347-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.